Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
Boehringer Ingelheim
Medtronic
Moodys

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

ELSPAR Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ELSPAR

US Patents for ELSPAR

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial EnBio Limited (Dublin, IE) 2026-09-11 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Biogen Idec MA Inc. (Cambridge, MA) 2026-07-10 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial The American National Red Cross (Rockville, MD) 2010-11-27 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Kuraray Co., Ltd. (Kurashiki, JP) 2011-04-24 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial 3-V Biosciences, Inc. (Menlo Park, CA) 2035-01-07 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Dynavax Technologies Corporation (Berkeley, CA) 2035-06-01 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Georgia State University Research Foundation, Inc. (Atlanta, GA) 2033-03-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for ELSPAR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
300267 Netherlands   Start Trial PRODUCT NAME: PERFLUTREN BEVATTENDE LIPIDE-MICROBOLLEN; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
CA 2007 00027 Denmark   Start Trial PRODUCT NAME: PERFLUTREN-HOLDIGE LIPIDMIKROSAERER
SPC/GB07/031 United Kingdom   Start Trial PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
SZ 27/2007 Austria   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL
0790017-8 Sweden   Start Trial PRODUCT NAME: LIPIDMIKROSFAERER INNEHALLANDE PERFLUTREN; REG. NO/DATE: EU/1/06/361/001 20060920
91325 Luxembourg   Start Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
SZ 35/1996 Austria   Start Trial PRODUCT NAME: PEGYLIERTES LIPOSOMALES DOXORUBICIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
Dow
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.